Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „strong“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.5 · 29 Following concomitant administration of carbamazepine, a strong inducer of CYP3A4, and oral aripiprazole to
Eintrag öffnenAbilify Maintena · 4.5 · 7 Quinidine and other strong CYP2D6 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a
Eintrag öffnenAbilify Maintena · 4.5 · Carbamazepine and other CYP3A4 inducers Following concomitant administration of carbamazepine, a strong induce
Eintrag öffnenAbilify Maintena · 4.5 · Ketoconazole and other strong CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects,
Eintrag öffnenAbilify Maintena · 4.5 · Ketoconazole and other strong CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects,
Eintrag öffnenAbilify Maintena · 4.5 · Quinidine and other strong CYP2D6 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a s
Eintrag öffnenAbiraterone Mylan · 4.5 · Strong inducers of CYP3A4 (e.g., phenytoin, carbamazepine, rifampicin, rifabutin, rifapentine, phenobarbital,
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin with ketoconazole, a strong CYP3A4 and P-gp inhibitor, increased the
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin with rifampicin, a strong CYP3A4 inducer, did not alter the plasma ex
Eintrag öffnenAdempas · 4.5 · 8 Concomitant use with strong multi pathway CYP and P-gp/BCRP inhibitors The concomitant use of riociguat with
Eintrag öffnenAdempas · 4.5 · Concomitant use with other CYP and P-gp/BCRP inhibitors Medicinal products strongly inhibiting P-gp/BCRP such
Eintrag öffnenAdempas · 4.5 · Concomitant use with other CYP and P-gp/BCRP inhibitors Medicinal products strongly inhibiting P-gp/BCRP such
Eintrag öffnenAdempas · 4.5 · Concomitant use with strong multi pathway CYP and P-gp/BCRP inhibitors The concomitant use of riociguat with s
Eintrag öffnenAdempas · 4.5 · Riociguat and its main metabolite are strong inhibitors of CYP1A1 in vitro. Therefore, clinically relevant dru
Eintrag öffnenAdempas · 4.5 · Riociguat and its main metabolite are strong inhibitors of CYP1A1 in vitro. Therefore, clinically relevant dru
Eintrag öffnenAdempas · 4.5 · The concomitant use of riociguat with strong CYP3A4 inducers (e.g. phenytoin, carbamazepine, phenobarbitone or
Eintrag öffnenAdempas · 4.5 · The concomitant use of riociguat with strong CYP3A4 inducers (e.g. phenytoin, carbamazepine, phenobarbitone or
Eintrag öffnenAdvagraf · 4.5 · 10 Drug/Substance Class or Drug interaction effect Recommendations concerning Name co-administration Strong CY
Eintrag öffnenAkeega · 4.5 · In a separate clinical study in healthy subjects, co-administration of ketoconazole, a strong inhibitor of CYP
Eintrag öffnenAlecensa · 4.5 · CYP3A inducers Co-administration of multiple oral doses of 600 mg rifampicin once daily, a strong CYP3A induce
Eintrag öffnen